These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 16188946)

  • 21. Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
    Caspi D; Anouk M; Golan I; Paran D; Kaufman I; Wigler I; Levartovsky D; Litinsky I; Elkayam O
    Arthritis Rheum; 2006 Feb; 55(1):53-6. PubMed ID: 16463412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights to clinical use of serial determination in titers of cyclic citrullinated peptide autoantibodies.
    Kogure T; Tatsumi T; Fujinaga H; Niizawa A; Terasawa K
    Mediators Inflamm; 2007; 2007():12367. PubMed ID: 17497027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: the best diagnostic tool but also a great interest in prognosis].
    Lequerré T; Richez C
    Rev Prat; 2012 Oct; 62(8):1088-9. PubMed ID: 23227605
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical value of second- and third-generation assays of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.
    Kitahara K; Takagi K; Kusunoki Y; Nishio S; Nozaki T; Inomata H; Takei M; Sawada S; Kawai S
    Ann Rheum Dis; 2008 Jul; 67(7):1059-60. PubMed ID: 18556455
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative performance analysis of 4 different anti-citrullinated protein assays in the diagnosis of rheumatoid arthritis.
    Mutlu N; Bicakcigil M; Tasan DA; Kaya A; Yavuz S; Ozden AI
    J Rheumatol; 2009 Mar; 36(3):491-500. PubMed ID: 19228660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of anti-cyclic citrullinated peptide antibodies in predicting progression of palindromic rheumatism to rheumatoid arthritis.
    Russell AS; Devani A; Maksymowych WP
    J Rheumatol; 2006 Jul; 33(7):1240-2. PubMed ID: 16724377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does a positive anti-CCP test identify a distinct arthritis entity?
    Skogh T
    Arthritis Res Ther; 2005; 7(6):230-2. PubMed ID: 16277697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Very early 'Rheumatoid' arthritis cohorts: limited by selection.
    Inanc M
    Rheumatology (Oxford); 2007 Feb; 46(2):185-7. PubMed ID: 17043049
    [No Abstract]   [Full Text] [Related]  

  • 29. Production of anti-CCP antibodies and matrix metalloproteinase-3 by human rheumatoid arthritis synovial tissues using SCID mice.
    Iwaki-Egawa S; Matsuno H; Ogawa Y; Watanabe Y
    Ann Rheum Dis; 2005 Jul; 64(7):1094-5. PubMed ID: 15958770
    [No Abstract]   [Full Text] [Related]  

  • 30. Rheumatologic diagnostic serology: tests which test clinicians.
    Wong ML
    N Z Med J; 2004 Oct; 117(1203):U1095. PubMed ID: 15477919
    [No Abstract]   [Full Text] [Related]  

  • 31. Anti-cyclic citrullinated peptide (CCP) antibodies in patients with long-standing rheumatoid arthritis and their relationship with extra-articular manifestations.
    Korkmaz C; Us T; Kaşifoğlu T; Akgün Y
    Clin Biochem; 2006 Oct; 39(10):961-5. PubMed ID: 16979149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testing for anti-cyclic citrullinated peptide antibodies: is it time to set this genie free?
    Shmerling RH
    Arch Intern Med; 2009 Jan; 169(1):9-14. PubMed ID: 19139318
    [No Abstract]   [Full Text] [Related]  

  • 33. Anti-cyclic citrullinated peptide antibodies in lung diseases associated with rheumatoid arthritis.
    Inui N; Enomoto N; Suda T; Kageyama Y; Watanabe H; Chida K
    Clin Biochem; 2008 Sep; 41(13):1074-7. PubMed ID: 18638466
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-cyclic citrullinated peptide testing for the diagnosis of rheumatoid arthritis and the quest for improved sensitivity and predictive value.
    Levesque MC; Zhou Z; Moreland LW
    Arthritis Rheum; 2009 Aug; 60(8):2211-5. PubMed ID: 19644881
    [No Abstract]   [Full Text] [Related]  

  • 35. Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis.
    van Venrooij WJ; Zendman AJ; Pruijn GJ
    Autoimmun Rev; 2006 Nov; 6(1):37-41. PubMed ID: 17110315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response.
    Verpoort KN; Jol-van der Zijde CM; Papendrecht-van der Voort EA; Ioan-Facsinay A; Drijfhout JW; van Tol MJ; Breedveld FC; Huizinga TW; Toes RE
    Arthritis Rheum; 2006 Dec; 54(12):3799-808. PubMed ID: 17133560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum autoantibodies that bind citrullinated fibrinogen are frequently found in patients with rheumatoid arthritis.
    Hill JA; Al-Bishri J; Gladman DD; Cairns E; Bell DA
    J Rheumatol; 2006 Nov; 33(11):2115-9. PubMed ID: 16924693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New diagnostic and evaluative tests for rheumatoid arthritis].
    Hayashi N; Nishimura K; Morinobu A; Kumagai S
    Rinsho Byori; 2007 Apr; 55(4):388-96. PubMed ID: 17511271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative clinical rheumatology: why is a test for anti-CCP antibodies included in most routine care for rheumatoid arthritis while a HAQ/MDHAQ remains largely a research tool?
    Pincus T; Yazici Y; Bergman MJ
    J Rheumatol; 2009 Aug; 36(8):1563-4. PubMed ID: 19671805
    [No Abstract]   [Full Text] [Related]  

  • 40. Diagnostic value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.
    Mofidi M; Moghadam A
    Saudi Med J; 2008 Aug; 29(8):1206-7. PubMed ID: 18690324
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.